Morningstar has reaffirmed its fair value estimate of $66 per share for Bristol-Myers Squibb (BMY), underscoring the company’s strong pipeline, wide economic moat, and solid financial position desp
Prabhudas Lilladher has reaffirmed its BUY recommendation on Cipla, driven by the company's strong financial performance and strategic growth initiatives.
Natco Pharma has achieved a significant milestone with the approval from the United States Food and Drug Administration (USFDA) for its generic version of Everolimus tablets for oral suspen
Biocon shares were trading 3.3% higher in today's session at Rs 391 at the time of publication of this story. The stock opened at Rs 384 and touched an intraday high at Rs 394.50.
